Cell Culture Market Report 2025

This Cell Culture market report provides a comprehensive analysis of the market’s characteristics, size, and growth, including segmentation, regional and country-level breakdowns, competitive landscape, market shares, trends, and strategies. It also tracks historical and forecasted market growth across various geographies.

The cell culture market size has grown rapidly in recent years. It will grow from $27.85 billion in 2024 to $31.14 billion in 2025 at a compound annual growth rate (CAGR) of 11.8%. The growth in the historic period can be attributed to increasing demand for cell culture products, growing vaccine production, growing demand for 3d cell culture, and demand for cell culture consumables.

The cell culture market size is expected to see strong growth in the next few years. It will grow to $43.72 billion in 2029 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to expansion of cell therapy, precision medicine, globalization of research and production, cell-based assays. Major trends in the forecast period include advances in cell culture technology, bioprocessing technologies, advanced cell imaging, integration of automation, and biomanufacturing data management.

The ascent in demand for cell therapy is poised to be the primary driver behind the expansion of the cell culture market. Cell therapy, involving the injection or implantation of viable cells to treat medical conditions, relies significantly on cell culture as an integral stage in its implementation. Gilead Sciences Inc., in February 2023, reported a notable 75% surge in cell therapy product sales, totaling $419 million in the fourth quarter of 2022 compared to the corresponding period in 2021. This underscores the critical role of cell culture in developing, producing, and commercializing cell therapies, potentially revolutionizing healthcare by targeting various ailments. The surge in cell therapy demand directly contributes to the burgeoning cell culture market.

The increasing demand for personalized medicine is anticipated to drive the growth of the cell culture market. Personalized medicines, often referred to as precision medicine, consist of medical treatments and therapies specifically tailored to the unique characteristics of individual patients. Cell culture is essential to personalized medicine, serving as a fundamental tool for research, drug development, disease modeling, and therapeutic applications designed for individual patients. For example, in August 2023, the NHS Business Services Authority, a UK-based non-departmental public body under the Department of Health and Social Care, reported that there were 3.4 million patients in England prescribed diabetes medications in 2022-23, marking a 6% increase from the 3.2 million patients identified in 2021-22. Consequently, the rising demand for personalized medicine is significantly contributing to the growth of the cell culture market.

Key players in the cell culture market are innovating by introducing solutions like the cQrex portfolio to enhance cell culture efficiency and productivity, addressing existing challenges. Evonik Industries AG, in June 2023, launched the cQrex portfolio, incorporating peptides and the keto acid AKG, to optimize nutrient supply stability and solubility, thereby bolstering productivity. This portfolio caters specifically to cell culture scientists seeking improved efficiency and productivity, especially in high-value product production like monoclonal antibodies and vaccines. Its attributes, including high purity and versatility, make it a valuable asset for refining cell culture processes.

Strategic partnerships have become a cornerstone strategy among leading cell culture market players to fortify their capabilities, widen market presence, and sustain competitiveness. Collaborations, such as the partnership between Cytiva and Nucleus Biologics in January 2022, aim to expedite custom cell media development for cell and gene therapies. Such partnerships accelerate the progress of these therapies, enhancing accessibility for patients and signaling positive advancements within the cell and gene therapy sector.

In January 2022, Thermo Fisher Scientific Inc., a prominent biotechnology company based in the US, completed the acquisition of PeproTech Inc. for $1.85 billion. This strategic acquisition has significantly bolstered Thermo Fisher Scientific Inc.'s capabilities, particularly in catering to the swiftly growing cell and gene therapy market. It has also played a pivotal role in expanding Thermo Fisher's global footprint and commercial capacities.

Cell culture involves cultivating human, animal, or plant cells, along with microorganisms such as bacteria and yeast, within a laboratory setting. This method serves various purposes including research, drug testing, and diagnosing infections. These cells can originate from multicellular eukaryotes, established cell strains, cell lines, or a combination thereof.

The primary types of cell culture are primary cell culture, secondary cell culture, and cell lines. Primary cell cultures originate from tissue explants or specific cells derived from source tissues. Various types of media, both natural and artificial, are employed in applications such as stem cell technologies, cancer research, biopharmaceuticals, tissue engineering, regenerative medicine, among others.

The cell culture market research report is one of a series of new reports that provides cell culture market statistics, including cell culture industry global market size, regional shares, competitors with a cell culture market share, detailed cell culture market segments, market trends and opportunities, and any further data you may need to thrive in the cell culture industry. This cell culture market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Major companies operating in the cell culture market include Becton Dickinson, Corning Incorporation, Eppendorf, GE Healthcare, Merck KGaA, Thermo Fisher Scientific, Lonza Group, HiMedia Laboratories, Agilent Technologies Inc., PromoCell GmbH, CellGenix GmbH, InvivoGen, Greiner Bio-One, Irvine Scientific, Cell Culture Company (CCC) LLC, Sera Care Life Sciences Incorporation, American Type Culture Collection, Miltenyi Biotec, AITbiotech Pte Ltd., Bel-Art Products Inc., Sumitomo Bakelite, EMD Millipore, VWR International LLC, WHEATON IndustriesInc, Sartorius AG, Nunc Systems, Pall Corporation, PerkinElmer Genomics, Compagnie de Saint-Gobain S.A.

North America was the largest region in the cell culture market in 2024. The Middle East is expected to be the fastest growing region in the global cell culture market share during the forecast period. The regions covered in the cell culture market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa. The countries covered in the cell culture market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The cell culture market includes revenues earned by entities by diagnosing infections, testing new drugs, and conducting research. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 3-5 business days.